Acutus Medical Inc. (AFIB) News

Acutus Medical Inc. (AFIB): $0.16

0.03 (+27.60%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

F

Filter AFIB News Items

AFIB News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest AFIB News From Around the Web

Below are the latest news stories about ACUTUS MEDICAL INC that investors may wish to consider to help them evaluate AFIB as an investment opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

It's time to start Tuesday trading with a breakdown of the biggest pre-market stock movers worth keeping an eye on this morning!

William White on InvestorPlace | November 21, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Thursday!

William White on InvestorPlace | November 16, 2023

Acutus laying off 65% of employees to focus solely on Medtronic heart device deal

The company has decided to exit the mapping and ablation business and focus its remaining cash on the Medtronic partnership.

Yahoo | November 10, 2023

Acutus Medical Inc (AFIB) Reports Substantial Revenue Growth in Q3 2023 Despite Negative Gross ...

Improvements in Operating Efficiency and Strategic Partnerships Drive Performance

Yahoo | November 8, 2023

Acutus Medical Reports Third Quarter 2023 Financial Results

CARLSBAD, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB) today reported results for the third quarter of 2023. Recent Highlights: Third quarter revenue of $5.2 million grew 44% year-over-year, led by strong growth in distribution revenue from sales of left-heart access products to MedtronicRegistered significant year-over-year reductions in both GAAP and non-GAAP operating expenses and cash burn, resulting from disciplined focus on expen

Yahoo | November 8, 2023

Acutus Medical Announces Strategic Realignment of Resources and Corporate Restructuring

CARLSBAD, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), today announced a realignment of resources and corporate restructuring. Scott Huennekens, Chairman of Acutus, commented, “Following an extensive strategic review by the Company’s Board of Directors, we are taking the hard but necessary steps to streamline our operations. In light of the current financing environment and the capital investments required to achieve leadership in the

Yahoo | November 8, 2023

Acutus Medical to Announce Third Quarter 2023 Financial Results

CARLSBAD, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that it will release its third quarter 2023 financial results on Monday, November 13, 2023. In conjunction with the release, Acutus will host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent

Yahoo | November 2, 2023

Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CARLSBAD, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted equity awards on November 1, 2023 that were approved by the Compensation Committee of its Board of Directors under Company’s 2022 Inducement Equity Incentive Plan, as a material inducement to employment to 5 individuals hired by Acutus in October 2023. The equity aw

Yahoo | November 2, 2023

Acutus Medical, Inc. (NASDAQ:AFIB) Q2 2023 Earnings Call Transcript

Acutus Medical, Inc. (NASDAQ:AFIB) Q2 2023 Earnings Call Transcript August 7, 2023 Acutus Medical, Inc. misses on earnings expectations. Reported EPS is $-0.63 EPS, expectations were $0.61. Operator: Good day, and thank you for standing by, and welcome to the Acutus Medical Second Quarter 2023 Earnings Conference Call. [Operator Instructions] Please be advised that today’s […]

Yahoo | August 8, 2023

Q2 2023 Acutus Medical Inc Earnings Call

Q2 2023 Acutus Medical Inc Earnings Call

Yahoo | August 8, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!